Loading…
Loading…
New York, New York--(Newsfile Corp. - July 23, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ: EMBC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026, both dates inclusive (the "Class Period").
Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the Embecta Corp. Securities Class Action Where Shareholders Lost $5.35 Per Share NEW YORK, July 23, 2026 /PRNewswire/ -- IMPORTANT DATE: August 17, 2026. Investors who purchased Embecta Corp. (NASDAQ: EMBC) securities between November 25, 2025 and May 4, 2026 and wish to seek appointment as lead plaintiff must file a motion by this date.
NEW YORK, July 23, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive. Should You Join The Embecta Class Action Lawsuit : Do you, or did you, own shares of Embecta Corp. (NASDAQ: EMBC)?
SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- Hagens Berman, a leading national shareholder rights law firm, is conducting an investigation into Embecta Corp. (NASDAQ: EMBC) regarding alleged violations of federal securities laws. This investigation follows the recent filing of a class action lawsuit in the U.S. District Court for the District of New Jersey, which alleges that Embecta misrepresented the commercial stability of its insulin pen needle business.
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the "Class Period"), of the important August 17, 2026 lead plaintiff deadline.
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 17, 2026 lead plaintiff deadline.
LOS ANGELES, July 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Embecta Corp. ("Embecta" or the "Company") (NASDAQ:EMBC). IF YOU SUFFERED A LOSS ON YOUR EMBECTA INVESTMENTS, CLICK HERE BEFORE AUGUST 17, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for EMBC and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.